Sharon F. McGee

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

Kristina Magnusson, Meike de Wit, Donal J. Brennan et al. · The American Journal of Surgical Pathology · 2011 · 247 citations

Cytokeratin 20, Medicine, Satb2 Expression +14

JAM‐A expression positively correlates with poor prognosis in breast cancer patients

Elaine McSherry, Sharon F. McGee, Karin Jirström et al. · International Journal of Cancer · 2009 · 137 citations · Full text

Breast Oncology, Pathology, Cancer Biology +17

Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment

Annette T. Byrne, Aisling O’Connor, Michael J. Hall et al. · British Journal of Cancer · 2009 · 100 citations · Full text

miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential <i>In Vitro</i>

Laoighse Mulrane, Stephen F. Madden, Donal J. Brennan et al. · Clinical Cancer Research · 2012 · 81 citations · Full text

Synergistic interaction between trastuzumab and EGFR/HER-2 tyrosine kinase inhibitors in HER-2 positive breast cancer cells

Norma O’Donovan, Annette T. Byrne, Aisling O’Connor et al. · Investigational New Drugs · 2010 · 46 citations

Breast Oncology, Medicine, Receptor Tyrosine Kinase +7